New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...

Researchers announced that they have achieved the world's first elucidation of how hydrogen produces free electrons through ...

Slower oxygen recovery after a 6-minute walk test may predict poorer lung function and a higher risk for disease progression in patients with fibrotic interstitial lung disease.

According to a new study, the score can accurately predict long-term outcomes in patients with IPF and ILD associated with connective tissue disease.

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

Innovative Trial Design to Directly Measure Microvascular Functional Effects of Inhaled Therapy at the Capillary level of Pulmonary Hypertension Patients with Interstitial Lung Disease (PH-ILD) ...

Brainomix, a global leader and pioneer of AI-powered imaging tools in lung fibrosis and stroke, today announced it was ...

Associate Professor Yuichiro Matsushita of Materials and Structures Laboratory, Institute of Science Tokyo, Mitsubishi Electric Corporation, Associate ...

Quantitative CT metrics can be used to define progressive pulmonary fibrosis and have prognostic value in patients with ...

Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 6, 2026, to report its financial results for the second quarter ended ...

A research team led by Yeon Dong-Geon of the Kyung Hee University College of Medicine has published it assessment of negative ...